JBHT's first-quarter 2026 revenues are expected to have improved year over year. Higher net interest expense might have hurt the bottom line.

LOS ANGELES, April 10, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Hercules Capital, Inc., (“Hercules” or the "Company") (NYSE: HTGC) investors of a class action on behalf of investors that bought securities between May 1, 2025 and January 27, 2026, inclusive (the “Class Period”). Hercules investors have until May 21, 2026 to file a lead plaintiff motion.

Silver moved higher, while platinum found itself under pressure in today's trading session.

On 04/03/26 Medallion filed an 8-K disclosing that it had defaulted on $73.5 million in debt This follows the Company's attempt and failure to raise $31.25 million in senior debt in February 2026 MFIN's commercial lending subsidiary was deemed to not “have a qualified management team” and is in default ZimCal privately WARNED Medallion about the issues in its commercial book in 2025 Medallion's leadership is destroying shareholder value and taking its stockholders for granted This situation is DIRECTLY A RESULT OF poor management and no board oversight MFIN's Price/Tangible Book is a terrible 0.85x and its stock is down …

Renowned investor Michael Burry has reaffirmed his bearish position on Palantir Technologies, even as a public endorsement from Donald Trump provided temporary support to the stock. In a Substack post published on Friday, Burry revealed that he continues to hold long-dated put options against the artificial intelligence software firm.

MA is facing new payment rails from stablecoins to AI agents, but its aggressive reinvention may keep it ahead of the disruption.

LOS ANGELES, April 10, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Aldeyra Therapeutics, Inc., (“Aldeyra” or the "Company") (NASDAQ: ALDX) investors of a class action on behalf of investors that bought securities between November 3, 2023 and March 16, 2026, inclusive (the “Class Period”). Aldeyra investors have until May 29, 2026 to file a lead plaintiff motion.

New York, New York--(Newsfile Corp. - April 10, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Apollo Global Management, Inc. (NYSE: APO) between May 10, 2021 and February 21, 2026, both dates inclusive (the "Class Period"), of the important May 1, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Apollo Global securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

SWK shows signs of recovery with aerospace growth and cost savings, but weak tools demand and high debt support a cautious "hold" stance.

Aris Mining Corporation (ARIS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Columbia Financial (CLBK) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Gold.com expands its buyback by 0.2M shares, citing balance-sheet flexibility and confidence as it balances investment with shareholder returns.

MIDD rides strong demand in food processing, with acquisitions and rising snack, bakery and protein trends boosting segment growth.

GE Aerospace's Defense & Propulsion unit gains traction with strong contracts, rising backlog and margin expansion-supporting continued growth momentum.

Quantum computing is no longer a physics experiment. Google's Willow chip, IBM's quantum roadmap expansion, and IonQ's commercial contracts have pushed the technology from research labs toward real enterprise applications.

Vanguard Total Stock Market ETF (NYSEARCA:VTI) holds roughly $2.1 trillion in assets and has earned its place in millions of retirement portfolios.

WD-40 Company NASDAQ: WDFC stock presented a buying opportunity ahead of its fiscal Q2 2026 earnings release, which analysts and institutional investors took advantage of. Following the release, results and guidance justified that support, validating the long-term outlook for cash flow and capital returns.

Eli Lilly launches oral GLP-1 pill Foundayo, pairing low-cost access with Amazon and GoodRx partnerships to challenge rivals in the fast-growing obesity market.

AWK's West Virginia unit is set to invest $1.6M in pipeline upgrades as part of broader infrastructure plans, highlighting ongoing efforts to modernize aging systems.

Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.